Rothblatt Martine A

Chairperson &CEO | Director

2 companies

Insider Signal Score

Good

Trades Analyzed

304

12M Win Rate

53.6%

Avg 3M Return

-6.6%

Avg 12M Return

-1.6%

Rothblatt Martine A is a Chairperson &CEO at UNITED THERAPEUTICS Corp with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 121 sells.

Estimated insider holdings value: $172.4M based on current market prices.

Holdings by Company

UTHRJul 30, 2026

Current Shares333.9K

Value$172.25M

Net Activity-397,910

Bought: 0Sold: 397.9K

BETAJun 11, 2026

Current Shares8.2K

Value$182.3K

Net Activity0

Bought: 0Sold: 0

Transaction History

Showing 10 filings (page 6)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jul 26, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$338.75	$2,439,009.69	-23.9%	+3.5%	-10.0%
Jul 24, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$334.69	$2,409,782.47	-26.7%	+11.7%	-7.6%
Jul 22, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$330.45	$2,379,244.24	-24.9%	+11.4%	-10.4%
Jul 18, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$332.74	$2,395,736.06	-24.9%	+12.6%	-11.2%
Jul 16, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$327.16	$2,355,544.26	-29.4%	+8.8%	-9.2%
Jul 12, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$325.46	$2,343,345.55	-30.0%	+10.3%	-8.0%
Jul 10, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$324.54	$2,336,704.42	-21.5%	+8.1%	-8.8%
Jul 8, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$315.15	$2,269,085.39	-35.8%	+10.4%	-7.1%
Jul 3, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$315.35	$2,270,542.22	-29.6%	+15.0%	-5.3%
Jul 1, 2024	UTHR United Therapeutics Corp	Chairperson &CEO	Sale+OE	7,200	$319.51	$2,300,438.97	-29.5%	+12.3%	-8.8%

← PrevPage 6Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC